Safety of bowel cleasing agents for colon capsule endoscopy and conventional colonoscopy

Safety of bowel cleasing agents for colon capsule endoscopy and conventional colonoscopy - Safety of bowel cleasing agents

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013041

Enrollment

120

Registered

2014-02-01

Start date

2015-03-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Male and female older than 19 years old which were diagnosed or suspected to have colorectal diseases.

Exclusion criteria

Exclusion criteria: 1)Patients with dysphasia 2)Patietns who had allergy to agents used in this study. 3)Pregnant or possible pregnant women 4)Patients who will undergo MRI 2 weeks after colon capsule endoscopy 5)Patients with small and large bowel obstruction 6)Patients with stricture in small and large bowel 7)Patients with glucose-6-phosphate dehydrogenase deficiency

Design outcomes

Primary

Measure	Time frame
Vital sign, blood and urine analysis before and after colonic examination	—

Secondary

Measure	Time frame
Cleasing grades, duration of bowel cleasing, and acceptablity of cleasing agents.	—

Countries

Japan

Contacts

Public ContactNaoki Ohmiya

Fujita Health University School of Medicine Department of Gastroenterology

nohmiya@fujita-hu.ac.jp0562-93-9240

Outcome results